OBJECTIVE: To assess the influence of antibiotics on the value of various cytological parameters, and their combinations, in diagnosing ventilator-associated pneumonia (VAP). DESIGN: Prospective study. SETTING: The general intensive care unit (17 beds) of the University Hospital Maastricht. PATIENTS: Three hundred and thirty-five episodes of clinically suspected VAP (defined by the clinical and radiological criteria previously described by Bonten et al.) in 282 patients were studied. INTERVENTIONS: No additional interventions were conducted. MEASUREMENTS AND RESULTS: Bronchoalveolar lavage fluid cytology included a total cell count per millilitre, differential cell count and the percentage of infected cells (cells containing phagocytised organisms). Antibiotic therapy from 72 h prior to lavage was recorded. Areas under the curve (AUCs) of receiver operating characteristic curves were calculated for various cytological parameters and their combinations, in patients with and without antibiotic therapy. In 126 episodes (37.6%) in 106 patients, VAP was confirmed. There was no difference in AUCs between patients with and without antibiotic therapy for any parameter studied. The most prominent AUCs were (for patient groups with and without antibiotics combined): total cell count, 0.65; percentage polymorphonuclear neutrophils, 0.71; and percentage infected cells, 0.90. The combination of percentage infected cells with any other cytological parameter did not increase the AUC. CONCLUSION: Antibiotic therapy did not influence the predictive value of the percentage infected cells in BALF in diagnosing VAP.
OBJECTIVE: To assess the influence of antibiotics on the value of various cytological parameters, and their combinations, in diagnosing ventilator-associated pneumonia (VAP). DESIGN: Prospective study. SETTING: The general intensive care unit (17 beds) of the University Hospital Maastricht. PATIENTS: Three hundred and thirty-five episodes of clinically suspected VAP (defined by the clinical and radiological criteria previously described by Bonten et al.) in 282 patients were studied. INTERVENTIONS: No additional interventions were conducted. MEASUREMENTS AND RESULTS: Bronchoalveolar lavage fluid cytology included a total cell count per millilitre, differential cell count and the percentage of infected cells (cells containing phagocytised organisms). Antibiotic therapy from 72 h prior to lavage was recorded. Areas under the curve (AUCs) of receiver operating characteristic curves were calculated for various cytological parameters and their combinations, in patients with and without antibiotic therapy. In 126 episodes (37.6%) in 106 patients, VAP was confirmed. There was no difference in AUCs between patients with and without antibiotic therapy for any parameter studied. The most prominent AUCs were (for patient groups with and without antibiotics combined): total cell count, 0.65; percentage polymorphonuclear neutrophils, 0.71; and percentage infected cells, 0.90. The combination of percentage infected cells with any other cytological parameter did not increase the AUC. CONCLUSION: Antibiotic therapy did not influence the predictive value of the percentage infected cells in BALF in diagnosing VAP.
Authors: J Chastre; J L Trouillet; A Vuagnat; M L Joly-Guillou; H Clavier; M C Dombret; C Gibert Journal: Am J Respir Crit Care Med Date: 1998-04 Impact factor: 21.405
Authors: J A Jacobs; E I De Brauwer; G Ramsay; N A Cobben; S S Wagenaar; A J van der Ven; C A Bruggeman; M Drent Journal: Respir Med Date: 1999-08 Impact factor: 3.415
Authors: Jan Hayon; Corinne Figliolini; Alain Combes; Jean-Louis Trouillet; Najibi Kassis; Marie Christine Dombret; Claude Gibert; Jean Chastre Journal: Am J Respir Crit Care Med Date: 2002-01-01 Impact factor: 21.405
Authors: Johannes B J Scholte; Helke A van Dessel; Catharina F M Linssen; Dennis C J J Bergmans; Paul H M Savelkoul; Paul M H J Roekaerts; Walther N K A van Mook Journal: J Clin Microbiol Date: 2014-07-30 Impact factor: 5.948
Authors: Catharina F M Linssen; Jan A Jacobs; Foekje F Stelma; Walther N K A van Mook; Peter Terporten; Cornelis Vink; Marjolein Drent; Cathrien A Bruggeman; Annick Smismans Journal: Intensive Care Med Date: 2008-08-05 Impact factor: 17.440
Authors: Basem Al-Omari; Peter McMeekin; A Joy Allen; Ahsan R Akram; Sara Graziadio; Jana Suklan; William S Jones; B Clare Lendrem; Amanda Winter; Milo Cullinan; Joanne Gray; Kevin Dhaliwal; Timothy S Walsh; Thomas H Craven Journal: BMC Pulm Med Date: 2021-06-09 Impact factor: 3.317
Authors: Guy J Oudhuis; Dennis C Bergmans; Tom Dormans; Jan-Harm Zwaveling; Alfons Kessels; Martin H Prins; Ellen E Stobberingh; Annelies Verbon Journal: Intensive Care Med Date: 2010-08-19 Impact factor: 17.440
Authors: Marijke J Vanspauwen; Catharina F M Linssen; Cathrien A Bruggeman; Jan A Jacobs; Marjolein Drent; Dennis C J J Bergmans; Walther N K A van Mook Journal: Crit Care Date: 2011-01-11 Impact factor: 9.097
Authors: R M Schnabel; K van der Velden; A Osinski; G Rohde; P M H J Roekaerts; D C J J Bergmans Journal: BMC Pulm Med Date: 2015-09-29 Impact factor: 3.317
Authors: Guy J Oudhuis; Judith Beuving; Dennis Bergmans; Ellen E Stobberingh; Guul ten Velde; Catharina F Linssen; Annelies Verbon Journal: Intensive Care Med Date: 2009-04-03 Impact factor: 17.440
Authors: Johannes B J Scholte; Johan I M van der Velde; Catharina F M Linssen; Helke A van Dessel; Dennis C J J Bergmans; Paul H M Savelkoul; Paul M H J Roekaerts; Walther N K A van Mook Journal: BMC Pulm Med Date: 2015-08-12 Impact factor: 3.317